Skip to main content
Top
Published in: Cancer Causes & Control 6/2014

01-06-2014 | Original paper

Moderate alcohol intake and cancer: the role of underreporting

Authors: Arthur L. Klatsky, Natalia Udaltsova, Yan Li, David Baer, H. Nicole Tran, Gary D. Friedman

Published in: Cancer Causes & Control | Issue 6/2014

Login to get access

Abstract

Purpose

There is compelling evidence that heavy alcohol drinking is related to increased risk of several cancer types, but the relationship of light–moderate drinking is less clear. We explored the role of inferred underreporting among light–moderate drinkers on the association between alcohol intake and cancer risk.

Methods

In a cohort of 127,176 persons, we studied risk of any cancer, a composite of five alcohol-associated cancer types, and female breast cancer. Alcohol intake was reported at baseline health examinations, and 14,880 persons were subsequently diagnosed with cancer. Cox proportional hazard models were controlled for seven covariates. Based on other computer-stored information about alcohol habits, we stratified subjects into 18.4 % (23,363) suspected of underreporting, 46.5 % (59,173) not suspected of underreporting, and 35.1 % (44,640) of unsure underreporting status.

Results

Persons reporting light–moderate drinking had increased cancer risk in this cohort. For example, the hazard ratios (95 % confidence intervals) for risk of any cancer were 1.10 (1.04–1.17) at <1 drink per day and 1.15 (1.08–1.23) at 1–2 drinks per day. Increased risk of cancer was concentrated in the stratum suspected of underreporting. For example, among persons reporting 1–2 drinks per day risk of any cancer was 1.33 (1.21–1.45) among those suspected of underreporting, 0.98 (0.87–1.09) among those not suspected, and 1.20 (1.10–1.31) among those of unsure status. These disparities were similar for the alcohol-related composite and for breast cancer.

Conclusions

We conclude that the apparent increased risk of cancer among light–moderate drinkers may be substantially due to underreporting of intake.
Literature
1.
go back to reference Bagnardi V, Rota M, Botteri E, Tramaceri I, Islami F, Fedente V et al (2013) Light alcohol drinking and cancer: a meta-analysis. Ann Oncol 2:701–708 Bagnardi V, Rota M, Botteri E, Tramaceri I, Islami F, Fedente V et al (2013) Light alcohol drinking and cancer: a meta-analysis. Ann Oncol 2:701–708
2.
go back to reference Jin M, Cai S, Guo J, Zhu Y, Li M, Yu Y et al (2013) Alcohol drinking and all cancer mortality: a meta-analysis. Ann Oncol 3:807–816CrossRef Jin M, Cai S, Guo J, Zhu Y, Li M, Yu Y et al (2013) Alcohol drinking and all cancer mortality: a meta-analysis. Ann Oncol 3:807–816CrossRef
3.
go back to reference Li Y, Baer D, Friedman GD, Udaltsova N, Shim V, Klatsky AL (2008) Wine, liquor, beer and risk of breast cancer in a large population. Eur J Cancer 45(5):843–850PubMedCrossRef Li Y, Baer D, Friedman GD, Udaltsova N, Shim V, Klatsky AL (2008) Wine, liquor, beer and risk of breast cancer in a large population. Eur J Cancer 45(5):843–850PubMedCrossRef
4.
go back to reference Seitz HK, Pelucchi C, Bagnardi V, La Vecchia C (2012) Epidemiology and pathophysiology of alcohol and breast cancer: update 2012. Alcohol Alcohol 47(3):204–212PubMedCrossRef Seitz HK, Pelucchi C, Bagnardi V, La Vecchia C (2012) Epidemiology and pathophysiology of alcohol and breast cancer: update 2012. Alcohol Alcohol 47(3):204–212PubMedCrossRef
5.
go back to reference Winstanley MH, Pratt IS, Chapman K, Griffin HJ, Croager ST, Olver IN et al (2011) Alcohol and cancer: a position statement from Cancer Council Australia. Med J Aust 194(9):479–482PubMed Winstanley MH, Pratt IS, Chapman K, Griffin HJ, Croager ST, Olver IN et al (2011) Alcohol and cancer: a position statement from Cancer Council Australia. Med J Aust 194(9):479–482PubMed
6.
go back to reference Nelson DE, Jarman DW, Rehm J, Greenfield TK, Rey G, Kerr WC et al (2013) Alcohol-attributable cancer deaths and years of potential life lost in the United states. Am J Public Health 103(4):641–648PubMedCentralPubMedCrossRef Nelson DE, Jarman DW, Rehm J, Greenfield TK, Rey G, Kerr WC et al (2013) Alcohol-attributable cancer deaths and years of potential life lost in the United states. Am J Public Health 103(4):641–648PubMedCentralPubMedCrossRef
7.
go back to reference Allen NE, Beral V, Casabonne D, Kan SW, Reeves GK, Brown A et al (2009) Moderate alcohol intake and cancer incidence in women. J Natl Cancer Inst 101(5):296–305PubMedCrossRef Allen NE, Beral V, Casabonne D, Kan SW, Reeves GK, Brown A et al (2009) Moderate alcohol intake and cancer incidence in women. J Natl Cancer Inst 101(5):296–305PubMedCrossRef
8.
go back to reference Klatsky AL (1994) Epidemiology of coronary heart disease—influence of alcohol. Alcohol Clin Exp Res 18(1):88–96PubMedCrossRef Klatsky AL (1994) Epidemiology of coronary heart disease—influence of alcohol. Alcohol Clin Exp Res 18(1):88–96PubMedCrossRef
9.
go back to reference Klatsky AL (1999) [Editorial]. Is it the drink or the drinker? Circumstantial evidence only raises a probability. Editorial. Am J Clin Nutr 69(1):2–3PubMed Klatsky AL (1999) [Editorial]. Is it the drink or the drinker? Circumstantial evidence only raises a probability. Editorial. Am J Clin Nutr 69(1):2–3PubMed
10.
go back to reference Klatsky AL, Gunderson E, D G, Kipp H, Udaltsova N, Friedman GD (2006) Higher prevalence of systemic HTN among moderate alcohol drinkers: exploring the role of under-reporting. J Stud Alcohol 67(3):421–428PubMed Klatsky AL, Gunderson E, D G, Kipp H, Udaltsova N, Friedman GD (2006) Higher prevalence of systemic HTN among moderate alcohol drinkers: exploring the role of under-reporting. J Stud Alcohol 67(3):421–428PubMed
11.
12.
go back to reference Collen MF, Davis LF (1969) The multitest laboratory in health care. J Occup Med 11(7):355–360PubMed Collen MF, Davis LF (1969) The multitest laboratory in health care. J Occup Med 11(7):355–360PubMed
13.
go back to reference Tran HN, Li Y, Siu D, Baer D, Friedman GD, Udaltsova N, Klatsky AL (2013) Predictors of lung cancer: noteworthy cell type differences. Perm J 17(2):23–29PubMedCentralPubMedCrossRef Tran HN, Li Y, Siu D, Baer D, Friedman GD, Udaltsova N, Klatsky AL (2013) Predictors of lung cancer: noteworthy cell type differences. Perm J 17(2):23–29PubMedCentralPubMedCrossRef
14.
go back to reference Klatsky AL, Armstrong MA, Landy C, Udaltsova N (2003) The effect of coronary disease on changes in drinking in an older population. Alcohol Res 8:211–213 Klatsky AL, Armstrong MA, Landy C, Udaltsova N (2003) The effect of coronary disease on changes in drinking in an older population. Alcohol Res 8:211–213
15.
go back to reference Klatsky AL, Armstrong MA, Kipp H (1990) Correlates of alcoholic beverage preference: traits of persons who choose wine, liquor, or beer. Br J Addict 85(10):1279–1289PubMedCrossRef Klatsky AL, Armstrong MA, Kipp H (1990) Correlates of alcoholic beverage preference: traits of persons who choose wine, liquor, or beer. Br J Addict 85(10):1279–1289PubMedCrossRef
16.
go back to reference Friedman GD, Klatsky AL (1994) Is alcohol good for your health? [Editorial]. N Engl J Med 329(25):1882–1883CrossRef Friedman GD, Klatsky AL (1994) Is alcohol good for your health? [Editorial]. N Engl J Med 329(25):1882–1883CrossRef
Metadata
Title
Moderate alcohol intake and cancer: the role of underreporting
Authors
Arthur L. Klatsky
Natalia Udaltsova
Yan Li
David Baer
H. Nicole Tran
Gary D. Friedman
Publication date
01-06-2014
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 6/2014
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-014-0372-8

Other articles of this Issue 6/2014

Cancer Causes & Control 6/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine